INTRANASAL AGENT "OKSOFIL" FOR TREATMENT AND PROPHYLAXIS OF RHINITIS OF DIFFERENT ETIOLOGY
FIELD: medicine, otorhinolaryngology, pharmacy. SUBSTANCE: invention relates to compositions used for external (intranasal) application. Invention relates to intranasal agent that comprises drops containing acutifoliate oxytropis (Oxytropis oxyphylla (Pall. ) DC) dry extract. Hydrophilic-base drops...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: medicine, otorhinolaryngology, pharmacy. SUBSTANCE: invention relates to compositions used for external (intranasal) application. Invention relates to intranasal agent that comprises drops containing acutifoliate oxytropis (Oxytropis oxyphylla (Pall. ) DC) dry extract. Hydrophilic-base drops are preferable in acute form of rhinitis and present extract suspension in hydroxymethylcellulose aqueous solution and comprise sorbic acid. Emulsion-base drops are preferable for recovery of mucosa tissue in chronic rhinitis and present emulsion-base suspension comprising peach oil, emulsifier T-2, preparation OS-20, propylene glycol, water and sorbic acid. Drops based on hydrophilic and emulsion bases are recommended in complex therapy route. Invention provides preparing nontoxic preparation without adverse effects. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 4 cl, 7 tbl, 3 dwg |
---|